ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia.
Times cited: 2
- Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells. Nature Genetics. 2017 Academic Article GET IT
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.
Times cited: 51
Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias.
Times cited: 8